ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis - Nature - Alert Breaking News - United States
Alert Breaking News - US,
Liu, H. et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss.
Liu, H. et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss.
NEW YORK – Researchers in France have developed an analytical tool that helps identify gene expression signatures associated…